• SENSEX 76,024.51
    -1,390.41 (--1.80%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • Vodafone Idea
    8.57 19.15(%)
  • Hind.Aeronautics
    4,492.80 5,675.00(%)
  • HBL Engineering
    532.15 738.65(%)
  • Reliance Industr
    1,250.00 1,156.00(%)
  • HDFC Bank
    1,765.00 1,430.15(%)
  • Galaxy Surfact.
    2,096.20 3,366.30(%)
  • Adani Green
    916.95 758.00(%)
  • ICICI Bank
    1,315.00 1,048.35(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Larsen & Toubro
    3,430.60 3,141.30(%)
  • Infosys
    1,518.00 1,359.10(%)
  • Bajaj Finance
    8,672.00 6,376.55(%)
  • Dixon Technolog.
    12,880.05 7,100.05(%)
  • IndusInd Bank
    689.85 1,576.00(%)
  • ITC
    405.50 381.24(%)
  • Nip. India Gold
    77.05 77.05(%)
  • St Bk of India
    763.05 679.65(%)
  • M & M
    2,625.00 1,891.30(%)
  • Trent
    5,619.85 8,345.85(%)
  • PB Fintech.
    1,505.90 1,110.25(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sun Pharmaceutical Industries Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Sun Pharma
  • BSE Code : 4325.0
  • ISIN : INE044A01036
1,698.35 -36 (-2.10%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    1,681.60

  • Today’s High

    1,733.95

  • Open

    1,731.00

  • Perv Close

    1,734.70

  • 52W Low

    1,377.20

  • 52W High

    1,960.35

Key Indicators

  • P/E(TTM)

    129.24

  • Mar.Cap (₹Cr.)

    407,491.05

  • Div & Yield %

    0.80

  • Book Value(₹)

    98.33

  • Debt-Equity Ratio

    -2.10

  • AGM Date

    01-Apr-2025

  • EPS

    13.13

  • P/E Ratio

    129.24

Financials Ratios

  • Debt-Equity Ratio

    0.08

  • Mar.Cap (₹Cr.)

    407,491.05

  • RONW (%)

    16.13

  • ROCE (%)

    17.20

Score Board

  • Equity (₹ in Cr.)

    239.93

  • BV (₹)

    98.30

  • Sales( ₹ in Cr.)

    20,275.17

  • NP (in Cr.)

    3,051.64

  • NP Var(%)

    -9.0

  • Div%

    1350.0

  • CPS (₹)

    19.40

  • EPS (₹)

    12.70

  • Traded Value (₹ in Lakhs)

    407,155.15

  • 52 Week High

    1,960.35

  • 52 Week Low

    1,377.20

  • Price BSE

    1697.0

  • Price NSE

    1,698.00

  • Market Capital( in Cr.)

    407,155.15

  • P/C Ratio

    87.50

  • P/E Ratio

    133.40

  • Price Vs.BV

    12.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 20,275.17 20,812.14 15,585.98 14,116.05 12,531.93 10,303.21
Excise Duty 19,843.53 20,394.63 15,518.50 13,988.40 11,906.74 9,783.29
Net Sales 20,275.17 20,812.14 15,585.98 14,116.05 12,531.93 10,303.21
Other Income 553.48 329.29 1,196.88 192.07 1,510.92 1,271.44
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 20,828.65 21,141.43 16,782.86 14,308.12 14,042.85 11,574.65
EXPENDITURE :
Raw Materials 19,843.53 20,394.63 15,518.50 13,988.40 11,906.74 9,783.29
Power & Fuel Cost 19,843.53 20,394.63 15,518.50 13,988.40 11,906.74 9,783.29
Employee Cost 2,373.95 2,156.95 2,000.78 1,805.98 1,702.77 1,571.34
Other Manufacturing Expenses 396.64 319.48 265.55 389.68 375.75 493.39
Selling & Administrative Expenses 4,754.86 4,326.42 3,759.99 3,549.24 2,149.04 1,718.62
Miscellaneous Expenses 396.64 319.48 265.55 389.68 375.75 493.39
Less : Pre-operative Expenses Capitalised :
Total Expenditure 17,159.98 16,462.59 14,655.47 13,362.99 10,789.85 9,640.82
Operating Profit 1,645.72 1,532.53 1,240.71 1,006.66 1,025.00 1,090.34
Interest 784.08 472.18 388.10 267.52 408.01 540.92
Gross Profit 3,449.65 1,741.05 306.86 855.57 3,253.00 719.45
Depreciation 1,600.62 1,600.87 1,349.95 1,236.43 561.56 552.95
Profit Before Tax 3,449.65 1,741.05 306.86 855.57 3,253.00 719.45
Tax 546.10 752.77 -553.58 244.91 386.46 1.55
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 45.37 -702.44 519.83 -231.74 -344.60 -98.70
Reported Net Profit 2,858.18 1,690.72 -99.99 842.40 3,211.14 816.60
Extraordinary Items 3,449.65 1,741.05 306.86 855.57 3,253.00 719.45
Adjusted Net Profit 2,858.18 1,690.72 -99.99 842.40 3,211.14 816.60
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 3,138.10 2,759.23 2,398.85 1,799.50 959.73 659.82
P & L Balance carried down 2,858.18 1,690.72 -99.99 842.40 3,211.14 816.60
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 1,350.00 1,150.00 1,000.00 750.00 400.00 275.00
Dividend Per Share(Rs) 13.50 11.50 10.00 7.50 4.00 2.75
Earnings Per Share-Unit Curr 11.90 7.00 -0.40 3.50 13.38 3.40
Book Value 3,138.10 2,759.23 2,398.85 1,799.50 959.73 659.82
Book Value(Adj)-Unit Curr 3,138.10 2,759.23 2,398.85 1,799.50 959.73 659.82

Shareholding Pattern

  • Promoter Group

    54.48%

  • Public Share Holding

    45.52%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,007,256,398 41.98 1,007,244,398 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 259,370,161 10.81 259,370,161 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 39,231,202 1.64 39,231,202 2
Trusts 1,276,774 0.05 1,276,774 1
Others 0 0.00 0 0
Sub Total 1,307,134,535 54.48 1,307,122,535 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 24,052 0.00 24,052 5
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,246,202 0.05 1,245,409 12
Foreign Bank 8,798 0.00 7,774 3
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 433,009,759 18.05 433,001,202 1,159
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 113,072,099 4.71 113,072,099 27
Mutual Funds / UTI 293,620,857 12.24 293,611,945 43
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 37,107,895 1.55 37,107,895 61
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 878,089,662 36.60 878,070,376 1,310
2] Non Institution
Bodies Corporate 50,296,454 2.10 50,237,288 2,791
Clearing Members 40,926 0.00 40,926 24
Directors of their Relatives 5,024,213 0.21 5,024,213 7
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 46,000 0.00 46,000 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,770,205 0.28 6,685,364 17,582
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 3,703,004 0.15 3,695,879 8,897
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 20,423,506 0.85 20,423,506 26
Individuals holding nominal share capital up to Rs. 1 lakh 110,722,270 4.61 106,978,549 658,658
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,589,817 0.07 1,589,817 42
Others 9,231,611 0.38 9,231,611 7
Sub Total 214,110,773 8.92 210,208,999 688,299
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 2,399,334,970 100.00 2,395,401,910 689,623

Company Background

Sun Pharmaceutical Industries LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Sun Pharmaceutical Industries Ltd
  • BSE Code : 4325.0
  • ISIN : INE044A01036

  • Incorporation Year

    1993

  • Registered Office

    Sun Pharma Advanced Res.Centre
    Tandalja, Vadodara,
    Gujarat-390020

  • Telephone

    91-265-6615500

  • FAX

    91-265-2354897

  • Chairman

    Dilip S Shanghvi

  • Managing Director

    Dilip S Shanghvi

  • Company Secretary

    Anoop Deshpande

  • Auditor

    S R B C & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Sun Pharmaceutical Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sun Pharma.Inds. 1,696.95 20,828.65 20,275.17 129.24 12.22
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92